PRECLINICAL STUDIES ON PARKINSON'S DISEASE
PharmaLegacy’s expertly executed studies empower confident Parkinson’s pipeline decisions.
PHARMALEGACY HAS THE EXPERTISE AND MODELS YOU NEED TO ADVANCE YOUR PARKINSON’S DISEASE PROGRAM.
MODELS / SERVICES
The tools to succeed:
- 1500+ validated animal models of disease spanning 100+ indications
- 30,000+ animal capacity
- Staffing and facilities to run 200+ concurrent studies
- Scientific staff with 15+ years of experience on average
- 380,000 square feet of facilities
PharmaLegacy has the capability and capacity to advance your Parkinson’s pipeline. Contact us today.
We’re ready when you are.
Tell us your Parksinson’s pipeline challenges.
